John David Finley, CEO, CFO, Director at PALISADE BIO, INC. (PALI), bought 10,000 shares at $0.56 ($6K) on 2024-01-31, disclosed to the SEC on 2024-02-01.
Open-market purchase of $6k PALI by CEO, CFO, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PALI | BUY | 2024-05-28 | $5K | — | Filing → |
| PALI | BUY | 2024-02-07 | $5K | — | Filing → |
| PALI | BUY | 2023-09-29 | $8K | — | Filing → |